Discover 1,359 paid clinical trials in Athens, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,359
Active & Responsive
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
for
Anemia, Sickle Cell, Healthy Volunteers
Location: Atlanta GA, Birmingham AL, Richmond VA, Fairfax VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06481306
Phase1, Phase2, Recruiting
Active & ResponsiveNew
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
for
Cutaneous Melanoma
Location: Atlanta GA, Birmingham AL, Corbin KY, Charleston SC,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 70+
Code: NCT07068074
Phase3, Recruiting
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: Atlanta GA, Forest City NC, Statesboro GA, Shelby NC,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 60+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
SynKIR-310 for Relapsed/Refractory B-NHL
for
B Cell Lymphoma, NHL, Adult, Mantle Cell Lymphoma,
Location: Atlanta GA, Philadelphia PA, New Brunswick NJ,
Sponsor: Verismo Therapeutics
Sex: All
Age: 18+
Code: NCT06544265
Phase1, Recruiting
Active & Responsive
Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer
for
Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation,
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT04878029
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
for
Glioblastoma, IDH-Wildtype
Location: Atlanta GA, Birmingham AL, Winston-Salem NC,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06319027
Phase2, Recruiting
Active & Responsive
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
for
Primary Myelofibrosis (PMF),
Location: Atlanta GA, Columbus OH, Indianapolis IN,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07357727
Phase3, Recruiting
Active & Responsive
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
for
Breast Cancer Triple Negative, Breast Cancer Stage II,
Location: Atlanta GA
Sponsor: Emory University
Sex: Female
Age: 18+
Code: NCT05877859
Recruiting
Active & Responsive
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT06492759
Phase2, Recruiting
Active & Responsive
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
for
Metastatic Colorectal Adenocarcinoma,
Location: Atlanta GA, Washington D.C. DC, Baltimore MD, Aurora CO
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07147231
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Location: Atlanta GA, Huntsville AL, Nashville TN,
Sponsor: C4 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07284758
Phase2, Recruiting
Active & Responsive
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
for
Colorectal Cancer, Colorectal Cancer (CRC),
Location: Atlanta GA, Jacksonville FL, Fairfax VA,
Sponsor: Cartography Biosciences
Sex: All
Age: 18+
Code: NCT07321106
Phase1, Recruiting
Active & Responsive
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
for
Solid Tumors
Location: Atlanta GA, Baltimore MD, New York NY, Houston TX
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07492680
Phase2, Recruiting
Active & Responsive
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Atlanta GA, Charlotte NC, Concord NC, Winston-Salem NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06287775
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
for
Solid Tumor, Non-Small-Cell Lung Cancer,
Location: Atlanta GA, Fairfax VA, Jefferson LA, St Louis MO,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT07094204
Phase1, Recruiting
Active & Responsive
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
for
Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm,
Location: Atlanta GA, Tampa FL, St Louis MO, Detroit MI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07114601
Phase1, Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Atlanta GA, Spartanburg SC, Knoxville TN,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase3, Recruiting
Active & Responsive
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
for
Bone Pain, Metastatic Malignant Neoplasm in the Bone,
Location: Atlanta GA, Philadelphia PA, New York NY, Boston MA,
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT03858205
Recruiting
Active & Responsive
Efficacy and Sustainability of a Carepartner-Integrated Telerehabilitation Program for Persons With Stroke